Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

Наши партнеры:

 

Новости/Аналитика

First 38 OTC Cannabinoid Products Approved in Mexico

21.12.2018

All approved products do not contain or contain a minimum amount (less than 1% of tetrahydrocannabinol) and can be sold without prescriptions or special permits.
 
For the first time, Mexican authorities have approved products derived from cannabis and containing cannabinoids for sale in OTC. Thirty-eight hemp products approved by the Mexican Federal Commission for Protection against Sanitary Risk (COFEPRIS) will be available in wholesale and retail networks, as well as through online trading channels until the end of this year.
 
Seven companies — four from Mexico, two from the United States and one from Spain — received permission to sell their goods over-the-counter, including:
 
• 21 nutritional supplements;
 
• 9 cosmetic products;
 
• 6 food or drinks;
 
• 2 types of raw materials.
 
All approved products do not contain or contain a minimum amount (less than 1% of tetrahydrocannabinol) and can be sold without prescriptions or special permits. COFEPRIS received 51 applications for distribution of cannabinoid goods in the country, but some of them were rejected.
 
As stated at a press conference organized specifically for the media, by the federal commissioner of COFEPRIS, Mr. Tepos (Julio Sanchez y Tepoz) “The Commission undertakes to timely respond to additional requests for the sale of cannabinoid products in the country if they will comply with the “Guidelines for health control when using cannabis and its derivatives specifically developed for this purpose” (“Lineamientos en materia de control sanitario de la cannabis y derivados de la misma“) ”.
 
“These permits were issued in accordance with the instructions recently published by COFEPRIS,” says Jose Alberto Campos Vargas, a lawyer at the Mexican law firm Sanchez DeVanny.
 
Commentary of the «Ukrainian Industrial Hemp Association»
 
The Guidelines on Health Monitoring for the Use of Cannabis and Its Derivatives will most likely be amended shortly due to the amendment of the current legislation of the country and the possibility of cultivating, processing and producing cannabinoid products in Mexico itself. Until the country has its own cannabinoid products, imported cannabis products or raw materials rich in cannabinoids will be brought into the country based on the guidelines of COFEPRIS.
Объявления
Все объявления »
 
 

facebook

telegram

twitter